Informative inducement: study payment as a signal of risk.
In research involving human subjects, large participation payments often are deemed undesirable because they may provide 'undue inducement' for potential participants to expose themselves to risk. However, although large incentives may encourage participation, they also may signal the riskiness of a study's procedures. In three experiments, we measured people's interest in participating in potentially risky research studies, and their perception of the risk associated with those studies, as functions of participation payment amounts. All experiments took place 2007-2008 with an on-line nationwide sample or a sample from a northeastern U.S. city. We tested whether people judge studies that offer higher participation payments to be riskier, and, if so, whether this increased perception of risk increases time and effort spent learning about the risks. We found that high participation payments increased willingness to participate, but, consistent with the idea that people infer riskiness from payment amount, high payments also increased perceived risk and time spent viewing risk information. Moreover, when a link between payment amount and risk level was made explicit in Experiment 3, the relationship between high payments and perceived risk strengthened. Research guidelines usually prohibit studies from offering participation incentives that compensate for risks, yet these experiments' results indicate that potential participants naturally assume that the magnitude of risks and incentives are related. This discrepancy between research guidelines and participants' assumptions about those guidelines has implications for informed consent in human subjects research.
Cryder
Cynthia E
CE
Washington University in St. Louis, St. Louis, MO, United States. Electronic address: cryder@wustl.edu.
John London
Alex
A
Carnegie Mellon University, Pittsburgh, PA, United States.
Volpp
Kevin G
KG
CHERP, Philadelphia VA Medical Center, University of Pennsylvania School of Medicine and the Wharton School, United States.
Loewenstein
George
G
Carnegie Mellon University, Pittsburgh, PA, United States.
D000328:Adult; D001294:Attitude to Health; D002986:Clinical Trials as Topic / Q000191:economics / Q000941:ethics*; D032984:Ethics, Research; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D057226:Information Seeking Behavior; D007258:Informed Consent / Q000941:ethics / Q000523:psychology; D020407:Internet; D008297:Male; D008875:Middle Aged; D009042:Motivation; D035842:Research Subjects / Q000191:economics / Q000523:psychology*; D012306:Risk; D012959:Socioeconomic Factors